Opportunistic CT Bone Density Screening Improves Osteoporosis Screening Rate
By Elana Gotkine HealthDay Reporter
MONDAY, March 10, 2025 -- Implementing opportunistic computed tomography (CT) bone density screening could increase the osteoporosis screening rate, yielding a reduction in medical costs, according to a study published in the March issue of the Journal of the American College of Radiology.
Soterios Gyftopoulos, M.D., from NYU Langone Health in New York City, and colleagues extracted data from the Medicare 5 Percent Research Identifiable Files (2015 to 2022) to examine the potential impact of opportunistic CT bone density screening.
The analysis included 2,897,040 beneficiaries, of whom 20.2 percent underwent dual-energy X-ray absorptiometry (DEXA), and 22.7 percent did not undergo DEXA but did undergo at least one CT scan that included the L1 vertebral body (67.8 and 32.2 percent without and with contrast, respectively). The researchers found that within one year of CT, there were 2,766 and 613 (0.6 and 0.3 percent) hip and 23,889 and 5,222 (5.3 and 2.5 percent) spine fragility fractures in the noncontrast and contrast CT groups, respectively. The osteoporosis screening rate would increase by 76 and 113 percent using only noncontrast CT studies and all CT studies, respectively. This study population would see a medical cost avoidance in excess of $17 million if only noncontrast CT was used to identify osteoporosis and treatment was successfully implemented in 100 percent of eligible beneficiaries. Potential annual cost avoidance for this study's population would be nearly $100 million, and it would be $2.5 billion for all 2023 Medicare fee-for-service beneficiaries if any CT was used.
"These findings provide additional support for incorporating opportunistic CT imaging into daily clinical practice," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Stopping Menopausal Hormone Therapy May Temporarily Increase Fracture Risk
WEDNESDAY, July 30, 2025 -- Stopping menopausal hormone therapy initially leads to several years of elevated fracture risk; however, this risk then decreases, first becoming...
ENDO: Osteoporosis Treatment Benefits Elderly Patients With Fragility Fracture
THURSDAY, July 17, 2025 -- Patients with osteoporosis who suffer a fragility fracture at age 80 years or older have better five-year outcomes if they receive treatment for...
AI Can Accurately Estimate Bone Mineral Density and Classify Osteoporosis
WEDNESDAY, July 16, 2025 -- An artificial intelligence (AI)-assisted diagnostic system can accurately estimate bone mineral density (BMD) and classify osteoporosis category...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.